➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Moodys
Baxter
Mallinckrodt

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: METHYLPHENIDATE HYDROCHLORIDE


Email this page to a colleague

« Back to Dashboard

METHYLPHENIDATE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-075-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-075-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-076-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-076-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-077-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-077-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-078-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-078-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-079-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-079-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-080-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-080-45) 2020-04-01
Rhodes Pharms APTENSIO XR methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205831 NDA AUTHORIZED GENERIC Rhodes Pharmaceuticals 42858-081-45 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42858-081-45) 2020-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Boehringer Ingelheim
McKinsey
Baxter
Dow